Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by malibukion Sep 11, 2017 9:21am
139 Views
Post# 26678796

RE:glutathione injections

RE:glutathione injections Here is a further and a bit more scientific paper on the IV application of glutathione. They also say that current data is not convincing to accept or decline the application.

https://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2017;volume=4;issue=1;spage=3;epage=6;aulast=Sonthalia

We continiously come across such reports on the need of safe and useful skin lightening agents. Unfortunately 1067 as well does not have any human data and Sirona claims rely on either in vitro (isolated system, lab tests) or skin patch studies. Unless we see further data it is still not clear 1067 will work and is safe on humans.

Personally I had not minded delays if these data was avalable. Either they are not investigated or not shared with the public. (I am talking on update like:  Double blind human study shows 1067 is 2-5x more efficient than any skin lightener on the market and less toxic). 3 years was long enough to conduct such study and would not cost that much I guess.

What we know from CEO videos etc is partner already confirmed Sirona's in vitro claims (at least something positive, partner could also have refused the findings) but it is not clear whether there were further analyses.

Ps. Quarterly report should come by the end of the month and we will have some idea whether they have enough cash until the deal.

GL


Bullboard Posts